Kuster Reintroduces Generic Drug Bill; Lawmakers Seek PBM, 340B Transparency

Rep. Ann Kuster (D-NH) reintroduced a bill aimed at boosting price transparency for generic drugs as lawmakers make a broader push to improve the enforcement and oversight of price transparency across the health care system to rein in rising costs. The Increasing Transparency in Generic Drug Applications Act, which Kuster first introduced last year, would address barriers to generic drug approval and expedite patient access to affordable medicines by clarifying that FDA can provide feedback to generic drug applicants on...